Rheumatoid lung disease with rheumatoid arthritis of multiple sites
ICD-10 M05.19 is a billable code used to indicate a diagnosis of rheumatoid lung disease with rheumatoid arthritis of multiple sites.
Rheumatoid lung disease is a serious complication of rheumatoid arthritis (RA), characterized by inflammation of lung tissue due to autoimmune processes. Anatomically, the lungs consist of lobes (right lung has three lobes, left lung has two) and are surrounded by pleura. In RA, the immune system mistakenly attacks the synovial membranes, leading to joint inflammation and systemic manifestations, including lung involvement. Clinically, patients may present with symptoms such as dyspnea, cough, and chest pain, alongside typical RA symptoms like joint swelling and stiffness. The pathophysiology involves the deposition of immune complexes in lung tissue, leading to interstitial lung disease, pleuritis, or pulmonary nodules. The presence of rheumatoid lung disease indicates a more severe form of RA, often correlating with increased morbidity and necessitating comprehensive management strategies.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage and functional assessments to evaluate mobility limitations.
Patients may require joint replacement surgery or arthroscopy due to severe joint damage from RA.
Documentation must specify which joints are involved and the severity of damage to guide treatment decisions.
Rheumatologic documentation should include laboratory tests for inflammatory markers (e.g., ESR, CRP) and assessments of disease activity (e.g., DAS28 score).
Management of RA may involve DMARDs, biologics, and monitoring for lung complications.
Systemic involvement must be documented, including any pulmonary function tests to assess lung capacity.
Functional assessments should evaluate the patient's ability to perform daily activities and any rehabilitation needs.
Rehabilitation may focus on improving mobility and strength, particularly in patients with significant joint involvement.
Mobility limitations due to both joint and lung involvement must be documented to justify therapy.
Used for follow-up visits for RA management with lung disease.
Documentation must include history, examination findings, and treatment plan.
Rheumatology focus on disease activity and lung function.
Common symptoms include persistent cough, shortness of breath, chest pain, and fatigue, often accompanied by the typical symptoms of rheumatoid arthritis such as joint pain and swelling.
